- Home
- SPPP vs FATE Comparison
SPPP vs FATE Comparison
Compare SPPP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- FATE
- Stock Information
- Founded
- SPPP 2011
- FATE 2007
- Country
- SPPP Canada
- FATE United States
- Employees
- SPPP N/A
- FATE N/A
- Industry
- SPPP
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPPP
- FATE Health Care
- Exchange
- SPPP NYSE
- FATE Nasdaq
- Market Cap
- SPPP 172.2M
- FATE 177.7M
- IPO Year
- SPPP N/A
- FATE 2013
- Fundamental
- Price
- SPPP $11.65
- FATE $1.12
- Analyst Decision
- SPPP
- FATE Hold
- Analyst Count
- SPPP 0
- FATE 7
- Target Price
- SPPP N/A
- FATE $3.83
- AVG Volume (30 Days)
- SPPP 183.3K
- FATE 2.2M
- Earning Date
- SPPP 01-01-0001
- FATE 08-12-2025
- Dividend Yield
- SPPP N/A
- FATE N/A
- EPS Growth
- SPPP N/A
- FATE N/A
- EPS
- SPPP N/A
- FATE N/A
- Revenue
- SPPP N/A
- FATE $13,335,000.00
- Revenue This Year
- SPPP N/A
- FATE N/A
- Revenue Next Year
- SPPP N/A
- FATE N/A
- P/E Ratio
- SPPP N/A
- FATE N/A
- Revenue Growth
- SPPP N/A
- FATE 105.85
- 52 Week Low
- SPPP $8.55
- FATE $0.66
- 52 Week High
- SPPP $11.39
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- SPPP 73.98
- FATE 41.69
- Support Level
- SPPP $11.36
- FATE $1.11
- Resistance Level
- SPPP $11.58
- FATE $1.23
- Average True Range (ATR)
- SPPP 0.27
- FATE 0.15
- MACD
- SPPP 0.03
- FATE -0.04
- Stochastic Oscillator
- SPPP 89.54
- FATE 2.04
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.